OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
CGON holding history
CG Oncology, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGON overviewAll 13F holders of CGONFull Q2 2026 holdings
- Shares (Q2 2026)
- 972,800
- Value
- $69.1M
- % of portfolio
- 1.3%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 972,800 | $69.1M | 1.3% | +24,533+2.6% | Added | Holders |
| Q1 2026 | 948,267 | $64.2M | 1.5% | −568,283−37.5% | Reduced | Holders |
| Q4 2025 | 1,516,550 | $63.0M | 1.3% | −210,300−12.2% | Reduced | Holders |
| Q3 2025 | 1,726,850 | $69.6M | 1.7% | −151,000−8.0% | Reduced | Holders |
| Q2 2025 | 1,877,850 | $48.8M | 1.2% | −594,144−24.0% | Reduced | Holders |
| Q1 2025 | 2,471,994 | $60.5M | 1.5% | +1,040,880+72.7% | Added | Holders |
| Q4 2024 | 1,431,114 | $41.0M | 0.9% | +740,000+107.1% | Added | Holders |
| Q3 2024 | 691,114 | $26.1M | 0.5% | +691,114 | New | Holders |